What's In A Name?

In the November 11, 1991, issue of The Scientist [page 13], you published an opinion piece by Ken Croswell entitled "Dealing With Problems On A First-Name Basis." I would like to respond to the opinions he expressed about the use of initials rather than first names on scientific publications. Croswell wonders if authors who use their initials rather than their first names on publications are "reclusive" or are attempting to "appear more scientific," and then notes that in such cases he

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

In the November 11, 1991, issue of The Scientist [page 13], you published an opinion piece by Ken Croswell entitled "Dealing With Problems On A First-Name Basis." I would like to respond to the opinions he expressed about the use of initials rather than first names on scientific publications.

Croswell wonders if authors who use their initials rather than their first names on publications are "reclusive" or are attempting to "appear more scientific," and then notes that in such cases he cannot tell if the scientist is male or female. For many of us who use our initials rather than our names, this is precisely the point. Women in the sciences, particularly the physical sciences, are all too accustomed to attracting notice first for our gender and only then for the quality of our science. Even if one is charitable enough to assume that the referee or reader of the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Le Mcneil

    This person does not yet have a bio.

Published In

Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with lipid nanoparticles

Thermo Fisher Logo
Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide

Explore a Concise Guide to Optimizing Viral Transduction

A Visual Guide to Lentiviral Gene Delivery

Takara Bio